Actinium Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Actinium Pharmaceuticals Inc cash flow-to-debt ratio. Actinium Pharmaceuticals Inc (ATNM) has a Cash Flow-to-Debt Ratio of -0.14x as of March 2026, meaning its operating cash flow of $-5.87 Million could theoretically repay 0% of its total liabilities ($43.13 Million) in one year. Check Actinium Pharmaceuticals Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Actinium Pharmaceuticals Inc (2006–2025)
Cash flow-to-debt ratio of Actinium Pharmaceuticals Inc from 2006 to 2025. Historical debt coverage capacity for Actinium Pharmaceuticals Inc across 20 annual periods. Check Actinium Pharmaceuticals Inc (ATNM) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Actinium Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2006–2025)
Actinium Pharmaceuticals Inc cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for Actinium Pharmaceuticals Inc. For the full cash flow conversion analysis, see Actinium Pharmaceuticals Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.56x | $-24.58 Million | $43.94 Million | ▲ +25.3% |
| 2024 | -0.75x | $-33.07 Million | $44.14 Million | ▲ +28.7% |
| 2023 | -1.05x | $-47.34 Million | $45.07 Million | ▼ -679.7% |
| 2022 | 0.18x | $8.64 Million | $47.71 Million | ▲ +105.9% |
| 2021 | -3.05x | $-20.87 Million | $6.84 Million | ▲ +28.4% |
| 2020 | -4.26x | $-21.62 Million | $5.08 Million | ▼ -19.5% |
| 2019 | -3.56x | $-21.46 Million | $6.03 Million | ▼ -5.2% |
| 2018 | -3.39x | $-20.57 Million | $6.08 Million | ▲ +26.7% |
| 2017 | -4.62x | $-21.55 Million | $4.67 Million | ▼ -0.4% |
| 2016 | -4.60x | $-20.79 Million | $4.52 Million | ▼ -14.4% |
| 2015 | -4.02x | $-18.54 Million | $4.61 Million | ▼ -165.9% |
| 2014 | -1.51x | $-14.35 Million | $9.49 Million | ▼ -76.0% |
| 2013 | -0.86x | $-6.29 Million | $7.33 Million | ▲ +23.5% |
| 2012 | -1.12x | $-5.21 Million | $4.64 Million | ▼ -17695.7% |
| 2011 | 0.01x | $539.00 | $84.48K | ▼ -92.3% |
| 2010 | 0.08x | $7.83K | $94.77K | ▲ +143.3% |
| 2009 | -0.19x | $-18.78K | $98.41K | ▼ -4.1% |
| 2008 | -0.18x | $-13.96K | $76.18K | ▲ +53.1% |
| 2007 | -0.39x | $-15.49K | $39.64K | ▲ +47.4% |
| 2006 | -0.74x | $-14.03K | $18.87K | — |